Back to search
FDAFDA · Food and drugs·Recall number D-0235-2020

S-LIDOCAINE HCL 1% / PHENYLEPHRINE1.5% (PF) INJ SOLN, 1ml syringe, Red Mountain Compounding Rx

Published November 13, 2019 · Recall initiated: August 12, 2019

Summary

FDA records drug Class II recall D-0235-2020, published November 13, 2019 and initiated August 12, 2019. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: 3x1 ml syringe; Lot: Lot #: S06192019DT@02, Exp 8/19/19; S06262019DT@11, Exp 8/26/19; S07312019DH@06, Exp 9/31/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Distributor
Nationwide in the USA
Lot
Lot #: S06192019DT@02, Exp 8/19/19; S06262019DT@11, Exp 8/26/19; S07312019DH@06, Exp 9/31/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was S-LIDOCAINE HCL 1% / PHENYLEPHRINE1.5% (PF) INJ SOLN, 1ml syringe, Red Mountain Compounding Rx recalled?

Yes. FDA published recall D-0235-2020 on November 13, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter